Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash Flows From Operating Activities
Net income (loss)	$ 17,700	$ 13,502
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Net accretion of bond premium	259	1,665
Depreciation and amortization	2,496	2,672
Stock-based compensation expense	1,758	1,156
Net investment (gains) losses	793	1,291
Net cash flows from equity and trading investments	0	56,381
Deferred income tax expense (benefit)	(2,061)	(7,170)
Changes in:
Accrued investment income	354	(391)
Premiums receivable	(1,842)	(53,454)
Deferred policy acquisition costs	(4,626)	(8,678)
Reinsurance receivables	(1,392)	(16,702)
Prepaid reinsurance premiums	755	3,074
Income taxes receivable	6,284	9,939
Other assets	11,769	(65,029)
Losses and loss settlement expenses	19,677	52,130
Unearned premium	22,783	37,358
Accrued expenses and other liabilities	(39,568)	7,212
Other, net	535	1,206
Net cash provided by (used in) operating activities	35,674	36,161
Cash Flows From Investing Activities
Proceeds from sale of available-for-sale investments	24,318	88,378
Proceeds from call and maturity of available-for-sale investments	49,821	34,719
Proceeds from sale of other investments	3,148	4,739
Purchase of available-for-sale investments	(110,957)	(39,859)
Purchase of other investments	(11,986)	(1,494)
Net purchases and sales of property and equipment	(2,495)	(2,603)
Net cash provided by (used in) investing activities	(48,151)	83,880
Cash Flows From Financing Activities
Issuance of common stock	(732)	(256)
Payment of cash dividends	(4,062)	(4,046)
Net cash provided by (used in) financing activities	(4,794)	(4,302)
Net Change in Cash and Cash Equivalents	(17,271)	115,739
Cash and Cash Equivalents at Beginning of Period	200,949	102,046
Cash and Cash Equivalents at End of Period	183,678	217,785
Supplemental Disclosures of Cash Flow Information
Income taxes paid	0	12
Interest paid	$ 2,434	$ 859